Boston Scientific to acquire spine company for $850M+

Spinal Tech

Boston Scientific plans to acquire Relievant Medsystems, the company behind the Intracept intraosseous nerve ablation system.

The deal values Relievant Medsystems at $850 million, and additional payments are expected over the next three years, according to a Sept. 19 news release.

Intracept  is a minimally invasive, implant-free outpatient procedure aimed to address lower back pain. Its efficacy is backed by clinical trials.

The acquisition is explected to close in the first half of 2024.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers